Beijing Cancer Hospital

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
2	Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial	Completed	Closed	Anlotinib	NCT04106024
1	A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)	Active, not recruiting	Closed	Pimitespib + Imatinib	NCT05245968
1	A Study of NB003 in Patients With Advanced Malignancies	Active, not recruiting	Active	NB003	NCT04936178
1/2	A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor	Active, not recruiting	Closed	Avapritinib (CS3007)	NCT04254939
2/3	A Multicenter, Open-label Clinical Study to Evaluate the Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (GISTAR-1)	Not yet recruiting	Not yet activated	NB003	NCT07379047
1	A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1]	Recruiting	Active	IDRX-42	NCT05489237